المؤلفون: Mariottini A; Department of Neurosciences, Drug and Child Health, University of Florence, Florence, Italy.; Department of Neurology 2 and Tuscan Region MS Referral Centre, Careggi University Hospital, Florence, Italy., Bulgarini G; Department of Neurosciences, Drug and Child Health, University of Florence, Florence, Italy., Forci B; Department of Neurosciences, Drug and Child Health, University of Florence, Florence, Italy., Innocenti C; Cell Therapy and Transfusion Medicine Unit, Careggi University Hospital, Florence, Italy., Mealli F; Department of Statistics, Computer Science, Applications 'Giuseppe Parenti', University of Florence, Florence, Italy.; Florence Centre for Data Science, Florence, Italy., Mattei A; Department of Statistics, Computer Science, Applications 'Giuseppe Parenti', University of Florence, Florence, Italy.; Florence Centre for Data Science, Florence, Italy., Ceccarelli C; Department of Statistics, Computer Science, Applications 'Giuseppe Parenti', University of Florence, Florence, Italy., Repice AM; Department of Neurology 2 and Tuscan Region MS Referral Centre, Careggi University Hospital, Florence, Italy., Barilaro A; Department of Neurology 2 and Tuscan Region MS Referral Centre, Careggi University Hospital, Florence, Italy., Mechi C; Department of Neurology 2 and Tuscan Region MS Referral Centre, Careggi University Hospital, Florence, Italy., Saccardi R; Cell Therapy and Transfusion Medicine Unit, Careggi University Hospital, Florence, Italy., Massacesi L; Department of Neurosciences, Drug and Child Health, University of Florence, Florence, Italy.; Department of Neurology 2 and Tuscan Region MS Referral Centre, Careggi University Hospital, Florence, Italy.

المصدر: European journal of neurology [Eur J Neurol] 2022 Jun; Vol. 29 (6), pp. 1708-1718. Date of Electronic Publication: 2022 Feb 28.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 9506311 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1331 (Electronic) Linking ISSN: 13515101 NLM ISO Abbreviation: Eur J Neurol Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*/adverse effects , Multiple Sclerosis*/therapy , Multiple Sclerosis, Chronic Progressive*/drug therapy , Multiple Sclerosis, Relapsing-Remitting*/drug therapy, Humans ; Immunosuppression Therapy ; Recurrence ; Retrospective Studies ; Treatment Outcome

المؤلفون: Mariottini A; Department of Neurosciences, Drug and Child Health, University of Florence, Florence, Italy/Department of Neurology 2 and Multiple Sclerosis Regional Referral Centre, Careggi University Hospital, Florence, Italy., Filippini S; Department of Neurosciences, Drug and Child Health, University of Florence, Florence, Italy/Department of Neurology 2 and Multiple Sclerosis Regional Referral Centre, Careggi University Hospital, Florence, Italy., Innocenti C; Cell Therapy and Transfusion Medicine Unit, Careggi University Hospital, Florence, Italy., Forci B; Department of Neurosciences Drug and Child Health, University of Florence, Florence, Italy., Mechi C; Department of Neurology 2 and Multiple Sclerosis Regional Referral Centre, Careggi University Hospital, Florence, Italy., Barilaro A; Department of Neurology 2 and Multiple Sclerosis Regional Referral Centre, Careggi University Hospital, Florence, Italy., Fani A; Cell Therapy and Transfusion Medicine Unit, Careggi University Hospital, Florence, Italy., Carlucci G; Department of Neurosciences, Drug and Child Health, University of Florence, Florence, Italy/Department of Neurology 2 and Multiple Sclerosis Regional Referral Centre, Careggi University Hospital, Florence, Italy., Saccardi R; Cell Therapy and Transfusion Medicine Unit, Careggi University Hospital, Florence, Italy., Massacesi L; Department of Neurosciences, Drug and Child Health, University of Florence, Florence, Italy/Department of Neurology 2 and Multiple Sclerosis Regional Referral Centre, Careggi University Hospital, Florence, Italy., Repice AM; Department of Neurology 2 and Multiple Sclerosis Regional Referral Centre, Careggi University Hospital, Florence, Italy.

المصدر: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2021 Jan; Vol. 27 (1), pp. 61-70. Date of Electronic Publication: 2020 Feb 03.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation* , Multiple Sclerosis* , Multiple Sclerosis, Chronic Progressive*/therapy, Atrophy ; Brain/diagnostic imaging ; Humans ; Retrospective Studies ; Treatment Outcome

المؤلفون: Mariottini A; Department of Neurosciences Drug and Child Health, University of Florence, Florence.; Department of Neurology 2 and Multiple Sclerosis Regional Referral Centre, Careggi University Hospital, Florence., Innocenti C; Cell Therapy and Transfusion Medicine Unit, Careggi University Hospital, Florence, Italy., Forci B; Department of Neurosciences Drug and Child Health, University of Florence, Florence.; Department of Neurology 2 and Multiple Sclerosis Regional Referral Centre, Careggi University Hospital, Florence., Magnani E; Department of Neurosciences Drug and Child Health, University of Florence, Florence.; Department of Neurology 2 and Multiple Sclerosis Regional Referral Centre, Careggi University Hospital, Florence., Mechi C; Department of Neurology 2 and Multiple Sclerosis Regional Referral Centre, Careggi University Hospital, Florence., Barilaro A; Department of Neurology 2 and Multiple Sclerosis Regional Referral Centre, Careggi University Hospital, Florence., Nistri R; Department of Neurosciences Drug and Child Health, University of Florence, Florence., Fani A; Cell Therapy and Transfusion Medicine Unit, Careggi University Hospital, Florence, Italy., Saccardi R; Cell Therapy and Transfusion Medicine Unit, Careggi University Hospital, Florence, Italy., Massacesi L; Department of Neurosciences Drug and Child Health, University of Florence, Florence.; Department of Neurology 2 and Multiple Sclerosis Regional Referral Centre, Careggi University Hospital, Florence., Repice AM; Department of Neurology 2 and Multiple Sclerosis Regional Referral Centre, Careggi University Hospital, Florence.

المصدر: European journal of neurology [Eur J Neurol] 2019 Apr; Vol. 26 (4), pp. 624-630. Date of Electronic Publication: 2018 Dec 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 9506311 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1331 (Electronic) Linking ISSN: 13515101 NLM ISO Abbreviation: Eur J Neurol Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation/*adverse effects , Immunosuppressive Agents/*therapeutic use , Multiple Sclerosis, Relapsing-Remitting/*therapy , Natalizumab/*therapeutic use, Adult ; Female ; Humans ; Male ; Middle Aged ; Multiple Sclerosis, Relapsing-Remitting/drug therapy ; Retrospective Studies ; Treatment Outcome ; Withholding Treatment